Business description: Wasatch Pharmaceutical, Inc.

Executive Committee: Wasatch Pharmaceutical, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Gary V. Heesch
CEO | Chief Executive Officer | - | 01/11/2010 |
| President | - | 01/11/2010 | |
Robert Meader
SAM | Sales & Marketing | - | 02/11/2010 |
Company details: Wasatch Pharmaceutical, Inc.
Wasatch Pharmaceutical, Inc.
310 East 4500 South
84107, Murray
+

Other Personal Products
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.20% | +0.09% | -8.82% | -4.71% | 336B | ||
| +0.69% | +1.99% | -10.75% | +5.03% | 137B | ||
| +1.54% | -0.95% | +5.98% | +23.90% | 72.61B | ||
| -0.64% | -2.99% | -23.38% | -21.47% | 49.48B | ||
| +6.02% | +18.40% | +11.74% | -31.85% | 36.88B | ||
| +0.69% | -0.73% | -11.80% | -19.71% | 36.61B | ||
| +1.20% | +1.63% | -20.05% | -33.19% | 20.26B | ||
| +0.08% | +0.65% | +5.27% | +26.80% | 20.24B | ||
| +0.11% | -1.69% | +7.13% | +8.79% | 19.58B | ||
| Average | +1.21% | +1.71% | -4.96% | -5.16% | 81.04B | |
| Weighted average by Cap. | +1.17% | +0.58% | -7.30% | -2.84% |

















